Just the FAQs. A New Way to Experience the News.
Instead of a lengthy article, we give you the news in the format of an FAQ.
Here are Your Latest News FAQs
Get Ready for a Unique News Content Experience
D-Wave's Latest Quantum Computing Advancements: Hybrid Solver and New U.S. Quantum Computer
D-Wave Quantum Inc. has announced the introduction of a new hybrid quantum solver and the deployment of a second U.S.-based Advantage quantum …
August 27, 2024
Source
FAQ on Clene's Submission of Briefing Book to FDA for CNM-Au8(R) in ALS Treatment
Clene and its subsidiary Clene Nanomedicine Inc. plan to submit a briefing book to the FDA by July 13, 2024, as part of the process to seek approval …
August 27, 2024
Source
FAQ: Mullen Automotive's Class 3 Electric Truck Purchase by Dublin, Ohio
Mullen Automotive has received a purchase order from Dublin, Ohio, for its Class 3 electric truck, marking a significant step in the city's transition …
August 27, 2024
Source
FAQ on Clene's CNM-Au8(R) Updates at the Emerging Growth Conference
Clene Inc. presented updates on CNM-Au8(R), a potential treatment for neurodegenerative diseases like ALS and MS, at the Emerging Growth Conference, …
August 27, 2024
Source
FAQ on Mullen’s Subsidiary Bollinger Motors Warranty Coverage for B4 Chassis Cab
Mullen Automotive's subsidiary, Bollinger Motors, has announced full warranty coverage for its all-electric Class 4 commercial truck, the Bollinger B4 …
August 27, 2024
Source
FAQ: Mullen Automotive's European Order for 29 Mullen GOs
Mullen Automotive has received a purchase order for 29 Mullen GOs, its commercial micro-urban-delivery vehicles, from GAMA, a European distributor, …
August 27, 2024
Source
FAQ on Clene's CNM-Au8(R) and Gold Nanocrystal Technology Developments
Clene (NASDAQ: CLNN) is advancing its innovative gold nanocrystal technology, CNM-Au8(R), for treating neurodegenerative diseases like ALS and MS, …
August 27, 2024
Source
FAQ on D-Wave Quantum's New Quantum AI Solutions
D-Wave Quantum Inc. is expanding its product development to integrate quantum optimization with AI and ML, aiming to bring innovative Quantum AI …
August 27, 2024
Source
FAQ: Mullen Automotive's Order from DB Schenker for Campus EVs
Mullen Automotive has received an order for four Campus EVs from DB Schenker, to be used for mail and delivery on Intel's technology campus in …
August 27, 2024
Source
FAQ: Mullen Automotive's Participation at the 2024 SEUS-CP Business Forum
Mullen Automotive, an emerging EV manufacturer, is set to participate as an Anchor Organization and panelist at the 2024 SEUS-CP Business Forum in …
August 27, 2024
Source
FAQ on Clene's Participation in the Canaccord Genuity 44th Annual Growth Conference
Clene Inc., a clinical-stage biopharmaceutical company, is set to present at the Canaccord Genuity 44th Annual Growth Conference, highlighting its …
August 27, 2024
Source
FAQ: D-Wave Quantum Inc. Q2 2024 Financial Results Announcement
D-Wave Quantum Inc. (NYSE: QBTS) will release its Q2 2024 financial results on August 8, 2024, before the market opens, followed by a conference call …
August 27, 2024
Source
FAQ: Mullen Automotive's New bizEV Lease Program for Mullen ONE EV Cargo Van
Mullen Automotive introduces bizEV, a turnkey lease program for its Mullen ONE Class 1 EV cargo van, aimed at individuals, small businesses, and …
August 27, 2024
Source
FAQ on Clene's Innovative Nanotherapeutics for Neurodegenerative Diseases
Clene (NASDAQ: CLNN) is advancing the treatment of neurodegenerative diseases like ALS, MS, and PD through its innovative nanotherapeutic platform, …
August 27, 2024
Source
McEwen Mining Q2 2024 Results Conference Call FAQ
McEwen Mining announces its conference call and webcast to discuss the second-quarter 2024 financial results and project developments, scheduled for …
August 27, 2024
Source
Mullen Automotive (NASDAQ: MULN) Shares Update and Future Growth Plans FAQ
Mullen Automotive, an emerging EV manufacturer, shared an update from CEO David Michery highlighting the company's strong foundation for future …
August 27, 2024
Source
Clene Inc. Q2 2024 Financial Results and Updates on CNM-Au8 Programs FAQ
Clene Inc. released its Q2 2024 financial results and provided updates on its CNM-Au8 programs for treating ALS and Rett Syndrome, highlighting …
August 27, 2024
Source
FAQ on Clene's Feature in BioMedWire Podcast and Its Implications
Clene Inc., a biopharmaceutical company specializing in neurodegenerative disease treatments, was highlighted in a BioMedWire Podcast episode, …
August 27, 2024
Source
FAQ on Mullen Automotive's Promotion of John Taylor to President of Commercial EV Division
Mullen Automotive has promoted John Taylor to President of its Commercial EV Division, recognizing his 35 years of experience and pivotal role in …
August 27, 2024
Source